Originally published July 20 2005
Aspirin does not reduce women's cancer risk, study finds
by Mike Adams, the Health Ranger, NaturalNews Editor
A study in the Journal of the American Medical Association finds aspirin appears to have little effect on preventing cancer in women, although a separate study in the Journal of the National Cancer Institute finds men who took low dose aspirin over five years had a lower prostate cancer risk.
- Low-dose aspirin doesn't seem to help prevent cancer in women.
- A major study involving nearly 40-thousand healthy women found no cancer risk reduction from taking low-dose aspirin.
- Researchers at Brigham and Women's Hospital and Harvard Medical School found that aspirin had no observed effect on total cancer, breast cancer or colorectal cancer.
- Lead researcher Nancy Cook says there was a 22% reduction of lung cancer risk, but that the findings were inconclusive and more research is needed.
- Meanwhile, a separate study found that men who took aspirin over five years slightly lowered their risk for prostate cancer.
- The results won't help settle the debate over whether anti-inflammatory medicines could be used to prevent cancer.
- The women's study is published in the Journal of the American Medical Association.
- The men's study is in the Journal of the National Cancer Institute.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml